PhoenixBio Co (TSE:6190) OCF Margin %: 30.43% (As of Mar. 2026)


TSE:6190 PhoenixBio Co Ltd TSE:6190
62 GF Score
Price 円338.00
GF Value 円361.16
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is PhoenixBio Co OCF Margin %?

PhoenixBio Co TSE:6190 +4.32% 62 OCF Margin % is 30.43% as of Mar. 2026. GuruFocus rates TSE:6190 with a GF Score™ of 62/100 and a GF Value™ of 円361.16 (Fairly Valued). The stock has 5 warning signs investors should review. Among 957 Biotechnology companies, PhoenixBio Co ranks better than 71.68% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. PhoenixBio Co's Cash Flow from Operations for the six months ended in Mar. 2026 was 円246 Mil. PhoenixBio Co's Revenue for the six months ended in Mar. 2026 was 円809 Mil. Therefore, PhoenixBio Co's OCF Margin % for the quarter that ended in Mar. 2026 was 30.43%.

As of today, PhoenixBio Co's current OCF Yield % is 5.22%.

The historical rank and industry rank for PhoenixBio Co's OCF Margin % or its related term are showing as below:

TSE:6190' s OCF Margin % Range Over the Past 10 Years
Min: -20.75   Med: -2.79   Max: 13.06
Current: 4.4


During the past 12 years, the highest OCF Margin % of PhoenixBio Co was 13.06%. The lowest was -20.75%. And the median was -2.79%.

TSE:6190's OCF Margin % is ranked better than
71.68% of 957 companies
in the Biotechnology industry
Industry Median: -66.52 vs TSE:6190: 4.40


PhoenixBio Co OCF Margin % Related Terms


PhoenixBio Co OCF Margin % Historical Data

* Premium members only.

The historical data trend for PhoenixBio Co's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PhoenixBio Co OCF Margin % Chart

PhoenixBio Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.24 13.06 -4.62 -4.74 4.40

PhoenixBio Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.54 -12.08 2.95 -23.46 30.43

TSE:6190 vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, PhoenixBio Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhoenixBio Co OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PhoenixBio Co's OCF Margin % distribution charts can be found below:

* The bar in red indicates where PhoenixBio Co's OCF Margin % falls into.


TSE:6190
62GF Score
PhoenixBio Co Ltd TSE:6190
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PhoenixBio Co OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

PhoenixBio Co's OCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=68.857/1565.532
=4.40 %

PhoenixBio Co's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=246.265/809.18
=30.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 30.43% mean?
PhoenixBio Co (TSE:6190) has a OCF Margin % of 30.43% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PhoenixBio Co and its competitors. According to the industry distribution chart, PhoenixBio Co ranks #271 out of 957 companies in the Biotechnology industry, placing it in the top 28.3%.
Is PhoenixBio Co's OCF Margin % too high?
PhoenixBio Co's current OCF Margin % is 30.43%. Based on the distribution chart, PhoenixBio Co ranks #271 out of 957 companies in the Biotechnology industry, which is above the industry midpoint. Overall, PhoenixBio Co has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PhoenixBio Co's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PhoenixBio Co ranks #271 out of 957 companies for OCF Margin %. This puts PhoenixBio Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PhoenixBio Co and its competitors. PhoenixBio Co's current OCF Margin % is 30.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PhoenixBio Co stock overvalued right now?
Based on GuruFocus' analysis, PhoenixBio Co (TSE:6190) is currently considered Fairly Valued. The stock's GF Value™ is 円361.16, compared to a current price of 円338.00 — trading 6.4% below its estimated fair value. The current OCF Margin % is 30.43%. PhoenixBio Co's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For PhoenixBio Co (TSE:6190), the current OCF Margin % is 30.43% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PhoenixBio Co (TSE:6190) Overvalued in 2026?

Based on GuruFocus' analysis, PhoenixBio Co stock appears to be undervalued. The current stock price of 円338.00 is trading 6.4% below its estimated GF Value™ of 円361.16. GuruFocus considers PhoenixBio Co to be Fairly Valued.

Key valuation signals for TSE:6190:

  • OCF Margin %: 30.43%
  • GF Value™: 円361.16 vs. price of 円338.00 (6.4% below fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the TSE:6190 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PhoenixBio Co Business Description

Address 3-4-1, Kagamiyama, Hiroshima Prefecture, Higashi-Hiroshima, JPN, 739-0046
PhoenixBio Co Ltd conducts study services for drug discovery and early development. It provides outsourcing services for drug development. The Company uses PXB-Mouse to conduct the study. Its services include pharmacokinetics-related tests, safety tests, and hepatitis virus (HBV / HCV) related drug efficacy tests. Geographically, the company generates the majority of its revenue from USA.
62GF Score

Get the complete analysis for TSE:6190

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円338.00
Price
円361.16
GF Value